Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pharmacodynamics,”

7,359 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 7,359 results

Testing effectiveness (Phase 2)UnknownNCT01364155
What this trial is testing

Safety, Tolerability, PK, and PD of LIM-0705 in Subjects With Impaired Glucose Tolerance or Abnormal HOMA-IR

Who this might be right for
Impaired Glucose ToleranceInsulin Resistance
Limerick BioPharma 50
Early research (Phase 1)Study completedNCT01671085
What this trial is testing

LY3015014 in Healthy Participants With High Cholesterol

Who this might be right for
Healthy VolunteersHypercholesterolemia
Eli Lilly and Company 13
Early research (Phase 1)Study completedNCT02156544
What this trial is testing

Study to Investigate the Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of CKD-519

Who this might be right for
Dyslipidemia
Chong Kun Dang Pharmaceutical 41
Testing effectiveness (Phase 2)Study completedNCT02650193
What this trial is testing

The Safety And Effects Of One Or More Doses Of HSP-130 Injected Under The Skin In Women With Breast Cancer That Has Not Spread To Distant Sites In The Body.

Who this might be right for
Non-metastatic Breast Cancer
Pfizer 25
Testing effectiveness (Phase 2)Ended earlyNCT03781414
What this trial is testing

Study of Efficacy, Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) of an Anti-CD40 Monoclonal Antibody, CFZ533, in Liver Transplant Recipients With Additional 12-month Follow-up and Long-term Extension

Who this might be right for
Liver Transplant Rejection
Novartis Pharmaceuticals 129
Early research (Phase 1)Ended earlyNCT01534949
What this trial is testing

Provide Initial Evidence of Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy to Support the Pivotal CT-P10 Therapeutic Equivalence Trial

Who this might be right for
Diffuse Large B-Cell Lymphoma
Celltrion 1
Early research (Phase 1)Ended earlyNCT04240158
What this trial is testing

IW-6463 Safety Study in Healthy Elderly Subjects

Who this might be right for
Other
Tisento Therapeutics 24
Very early researchUnknownNCT03673215
What this trial is testing

The Tolerability，Safety，PK/PD Study of rhTPO in the Patients With Liver Function Impairment

Who this might be right for
Liver Cirrhosis
Shenyang Sunshine Pharmaceutical Co., LTD. 58
Testing effectiveness (Phase 2)Study completedNCT03516487
What this trial is testing

Safety and Tolerability of SYNB1618 in Healthy Adult Volunteers and Adult Subjects With Phenylketonuria

Who this might be right for
PhenylketonuriaHealthy
Synlogic 70
Testing effectiveness (Phase 2)Active Not RecruitingNCT04416984
What this trial is testing

Safety and Efficacy of ALLO-501A Anti-CD19 Allogeneic CAR T Cells in Adults with Relapsed/Refractory Large B Cell Lymphoma, Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma (ALPHA2)

Who this might be right for
Relapsed or Refractory Large B Cell Lymphoma, Relapsed or Refractory Chronic Lymphocytic Leukemia, Relapsed or Refractory Small Lymphocytic Lymphoma
Allogene Therapeutics 160
Not applicableStudy completedNCT01557985
What this trial is testing

Single Dose Pharmacokinetics and Pharmacodynamics of Bupivacaine Following Transversus Abdominis Plane (TAP) Block in Neonates

Who this might be right for
Postoperative Pain
Ann & Robert H Lurie Children's Hospital of Chicago 10
Early research (Phase 1)Ended earlyNCT00147485
What this trial is testing

An Intravenously Administered Cyclin-Dependent Kinase Inhibitor In Patients With Advanced Cancer

Who this might be right for
NeoplasmsLymphoma, Non-Hodgkin
Pfizer 37
Early research (Phase 1)Study completedNCT01973244
What this trial is testing

A Trial Investigating Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a Single Dose of Long-acting Growth Hormone (Somapacitan) Compared to Daily Dosing of Norditropin® SimpleXx® in Children With Growth Hormone Deficiency

Who this might be right for
Growth Hormone DisorderGrowth Hormone Deficiency in Children
Novo Nordisk A/S 32
Early research (Phase 1)Study completedNCT02461563
What this trial is testing

A Multiple-Dose Study to Evaluate MK-1075 in Hepatitis C Virus (HCV) Infected Participants (MK-1075-004)

Who this might be right for
Hepatitis C Virus Infection
Merck Sharp & Dohme LLC 12
Early research (Phase 1)Study completedNCT05249621
What this trial is testing

Phase 1 of of MZE001 in Healthy Volunteers

Who this might be right for
Healthy
Maze Therapeutics 121
Early research (Phase 1)Ended earlyNCT02460016
What this trial is testing

AK0529 in Infants Hospitalized With RSV

Who this might be right for
Respiratory Syncytial Virus Infections
Shanghai Ark Biopharmaceutical Co., Ltd. 1
Testing effectiveness (Phase 2)Looking for participantsNCT05970016
What this trial is testing

A Phase I/II Clinical Study in Patients with Advanced Solid Tumor.

Who this might be right for
Patients with Advanced Solid Tumors
Beijing Tide Pharmaceutical Co., Ltd 56
Early research (Phase 1)Study completedNCT00754143
What this trial is testing

Phase 1 Study of FG-3019 in Subjects With Type 1 or Type 2 Diabetes Mellitus and Diabetic Nephropathy

Who this might be right for
Diabetes MellitusDiabetic Nephropathy
Kyntra Bio 38
Early research (Phase 1)Study completedNCT02321644
What this trial is testing

Effect of UV Exposure on the PD of Multiple Doses of CC-90001 and Pilot Food Effect Study

Who this might be right for
Healthy Subjects
Celgene Corporation 26
Not applicableStudy completedNCT04866498
What this trial is testing

Pharmacotherapy Personalization of Cancer Patients

Who this might be right for
Head and Neck NeoplasmsOncologic Patients
Poznan University of Medical Sciences 22
Load More Results